Alexion says “no” to investor proactive sale demand — FDA approves first copycats of Novartis MS drug Gilenya — $178M stockpile of Merck ebola vaccine authorized — See more on our front page newsDismiss Notice
TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.Dismiss Notice
General Medical Sales [moved to new board at top o
Board for general discussions regarding medical device, supply, and equipment sales.